Who
Lichti Braeden
Director
Company insider
Files Form 4 as: Director and 10% owner, PMGC Holdings; 10% owner, Marizyme.
In numbers
- Trades disclosed
- 11
- Buys
- 3
- Sells
- 3
- Bought
- $37K
- Sold
- $37K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 29 Jun 2023
- Last trade
- 1 Jun 2026
- Last filed
- 2 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 2 Jun 2026 | ELAB PMGC Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,277 at $0.00 | filing |
| 1 Jun 2026filed 2 Jun 2026 | ELAB PMGC Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —450,277 at $0.00 | filing |
| 26 Mar 2025filed 28 Mar 2025 | ELAB PMGC HoldingsBiotechnology | SEC FORM 4 Code A | —3,336,437 at $0.00 | filing |
| 21 Dec 2023filed 28 Dec 2023 | Marizymeoption or derivative | SEC FORM 4 Code C | —2 at $0.00 | filing |
| 21 Dec 2023filed 28 Dec 2023 | Marizyme | SEC FORM 4 Code C | $382K3,815,294 at $0.10 | filing |
| 29 Aug 2023filed 8 Sep 2023 | Marizyme | SEC FORM 4 Sold | $18K105,000 at $0.17 | filing |
| 29 Aug 2023filed 7 Sep 2023 | Marizyme | SEC FORM 4 Bought | $18K105,000 at $0.17 | filing |
| 7 Jul 2023filed 8 Sep 2023 | Marizyme | SEC FORM 4 Sold | $9,70097,000 at $0.10 | filing |
| 7 Jul 2023filed 7 Sep 2023 | Marizyme | SEC FORM 4 Bought | $9,70097,000 at $0.10 | filing |
| 29 Jun 2023filed 8 Sep 2023 | Marizyme | SEC FORM 4 Sold | $9,569106,327 at $0.09 | filing |
| 29 Jun 2023filed 7 Sep 2023 | Marizyme | SEC FORM 4 Bought | $9,569106,327 at $0.09 | filing |
News
No headline names them, or the companies they trade most, lately.